CardioGenics
Toronto
About CardioGenics
CardioGenics is dedicated to develop more sensitive diagnostic test products to the IVD market. CardioGenics has started several developmental processes aimed to achieve its objective “to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies”.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.6M
- Funding stage: IPO
- Last round: Series Unknown (Feb 2011)
- Ticker: otcqb:CGNH
- Website: cardiogenics.com
- Phone: +1 9056739865
Industries & Categories
Biotechnology, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/cardiogenics-1858724 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.